Physician profile
Michael Robert Maher
NPI 1114928355
$464.99
in general payments reported to CMS, 2019-2025
11 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2022: $113 · 2023: $30.50 · 2024: $97.37 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $141.70 | 2022-2025 | Novachor, Affinity, Apligraf |
| Stryker Corporation | $69.81 | 2019-2024 | Prostep Mica |
| Nevro Corp. | $50.25 | 2022 | |
| Convatec INC. | $37.73 | 2025 | |
| Paragon 28, INC. | $36.21 | 2019-2023 | |
| Averitas Pharma INC. | $34.30 | 2024-2025 | Qutenza |
| Smith+Nephew, INC. | $30.85 | 2024 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $25.20 | 2019 | |
| Medtronic, INC. | $21.81 | 2024 | Closurefast |
| Glaxosmithkline, LLC. | $14.69 | 2025 | Arexvy |
| Microaire Surgical Instruments LLC | $2.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.